Physician profile
Sandra D Kaplan
NPI 1205019940
$6,986.53
in general payments reported to CMS, 2019-2025
42 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what 77% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $535 · 2021: $865 · 2022: $569 · 2023: $1,097 · 2024: $1,417 · 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,276.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,683.96 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $547.26 | 2021-2025 | Inceptiv, Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Abbott Laboratories | $500.04 | 2019-2025 | Eterna |
| Abbvie INC. | $383.64 | 2021-2025 | |
| Amgen INC. | $365.43 | 2019-2025 | Evenity |
| Biohaven Pharmaceuticals, INC. | $360.10 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $281.68 | 2019-2025 | Relistor |
| Saluda Medical Americas, INC. | $276.42 | 2023-2025 | Evoke, Evoke Scs |
| Relievant Medsystems, INC. | $263.31 | 2023 | Intracept |
| Nevro Corp. | $236.50 | 2022-2023 | Senza |
| Pfizer INC. | $229.84 | 2020-2025 | |
| Spinefrontier, INC. | $220.84 | 2024 | Inspan |
| Collegium Pharmaceutical, INC. | $220.09 | 2019-2025 | Belbuca, Xtampza |
| Vertos Medical, INC. | $142.51 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $126.38 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.